Abstract
Ten derivatives of N1 substituted/unsubstituted 5-(4-chlorophenyl)-3-(2-thienyl) pyrazoline were synthesised from chalcone-like intermediate and substituted phenyl hydrazines, hydrazine hydrate, and semi/thiosemicarbazide. The chemical structure of compounds was confirmed by means of IR, 1H NMR, mass spectroscopy, and elemental analysis. The antidepressant and anticonvulsant activities were investigated by Porsolt’s behavioural despair test (forced swimming) and maximum electroshock seizure test, respectively. Rota-Rod test was performed to assess any probable changes in motor coordination induced by the test compounds. Four compounds (IId, IIg, IIi, and IIj) exhibited good activity profile against depression and docking studies confirmed their consensual interaction with monoamine oxidase A. In addition, compounds IIc and IIe showed protection against MES-induced seizures.
Similar content being viewed by others
References
Amnerkar, N. D., & Bhusari, K. P. (2010). Synthesis, anticonvulsant activity and 3D-QSAR study of some prop-2-eneamido and 1-acetyl-pyrazolin derivatives of aminoben zothiazole. European Journal of Medicinal Chemistry, 45, 149–159. DOI: 10.1016/j.ejmech.2009.09.037.
Amr, A. E. E., Abdel-Latif, N. A., & Abdalla, M. M. (2006). Synthesis and antiandrogenic activity of some new 3-substituted androstano[17,16-c]-5′-aryl-pyrazoline and their derivatives. Bioorganic & Medicinal Chemistry, 14, 373–384. DOI: 10.1016/j.bmc.2005.08.024.
Bourin, M., Hascoët, M., Colombel, M. C., Coutts, R. T., & Baker, G. B. (2002). Clonidine potentiates the effects of tranylcypromine, phenelzine and two analogues in the forced swimming test in mice. Journal of Psychiatry & Neuroscience, 27, 178–185.
Casimiro-Garcia, A., Dudley, D. A., Heemstra, R. J., Filipski, K. J., Bigge, C. F., & Edmunds, J. J. (2006). Progress in the discovery of factor Xa inhibitors. Expert Opinion on Therapeutic Patents, 16, 119–145. DOI: 10.1517/13543776.16.2.119.
Chimenti, F., Bolasco, A., Manna, F., Secci, D., Chimenti, P., Befani, O., Turini, P., Giovannini, V., Mondovì, B., Cirilli, R., & La Torre, F. (2004). Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase. Journal of Medicinal Chemistry, 47, 2071–2074. DOI: 10.1021/jm031042b.
Chimenti, F., Carradori, S., Secci, D., Bolasco, A., Bizzarri, B., Chimenti, P., Granese, A., Yáñez, M., & Orallo, F. (2010). Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives. European Journal of Medicinal Chemistry, 45, 800–804. DOI: 10.1016/j.ejmech.2009.11.003.
Chimenti, F., Fioravanti, R., Bolasco, A., Manna, F., Chimenti, P., Secci, D., Rossi, F., Turini, P., Ortuso, F., Alcaro, S., & Cardia, M. C. (2008). Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives. European Journal of Medicinal Chemistry, 43, 2262–2267. DOI: 10.1016/j.ejmech.2007.12.026.
De Colibus, L., Li, M., Binda, C., Lustig, A., Edmondson, D. E., & Mattevi, A. (2005). Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B. Proceedings of the National Academy of Sciences USA, 102, 12684–12689. DOI: 10.1073/pnas.0505975102.
El-Wahab, A. H. F. A., Al-Fifi, Z. I. A., Bedair, A. H., Ali, F. M., Halawa, A. H. A., & El-Agrody, A. M. (2011). Synthesis, reactions and biological evaluation of some new naphtho[2,1-b]furan derivatives bearing a pyrazole nucleus. Molecules, 16, 307–318. DOI: 10.3390/molecules16010307.
Fioravanti, R., Bolasco, A., Manna, F., Rossi, F., Orallo, F., Ortuso, F., Alcaro, S., & Cirilli, R. (2010). Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors. European Journal of Medicinal Chemistry, 45, 6135–6138. DOI: 10.1016/j.ejmech.2010.10.005.
Fowler, J. S., Logan, J., Azzaro, A. J., Fielding, R. M., Zhu, W., Poshusta, A. K., Burch, D., Brand, B., Free, J., Asgharnejad, M., Wang, G. J., Telang, F., Hubbard, B., Jayne, M., King, P., Carter, P., Carter, S., Xu, Y., Shea, C., Muench, L., Alexoff, D., Shumay, E., Schueller, M., Warner, D., & Apelskog-Torres, K. (2010). Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAO-A by CX157. Neuropsychopharmacology, 35, 623–631. DOI: 10.1038/npp.2009.167.
Gok, S., Demet, M. M., Özdemir, A., & Turan-Zitouni, G. (2010). Evaluation of antidepressant-like effect of 2-pyrazoline derivatives. Medicinal Chemistry Research, 19, 94–101. DOI: 10.1007/s00044-009-9176-x.
Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004). Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. Journal of Medicinal Chemistry, 47, 1750–1759. DOI: 10.1021/jm030644s.
Jia, Z., & Zhu, Q. (2010). ’Click’ assembly of selective inhibitors for MAO-A. Bioorganic & Medicinal Chemistry Letters, 20, 6222–6225. DOI: 10.1016/j.bmcl.2010.08.104.
Kaplancikli, Z. A., Özdemir, A., Turan-Zitouni, G., Altintop, M. D., & Can, O. D. (2010). New pyrazoline derivatives and their antidepressant activity. European Journal of Medicinal Chemistry, 45, 4383–4387. DOI: 10.1016/j.ejmech.2010.06.011.
Karuppasamy, M., Mahapatra, M., Yabanoglu, S., Ucar, G., Sinha, B. N., Basu, A., Mishra, N., Sharon, A., Kulandaivelu, U., & Jayaprakash, V. (2010). Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies. Bioorganic & Medicinal Chemistry, 18, 1875–1881. DOI: 10.1016/j.bmc.2010.01.043.
Krall, R. L., Penry, J. K., White, B. G., Kupferberg, H. J., & Swinyard, E. A. (1978). Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia, 19, 409–428. DOI: 10.1111/j.1528-1157.1978.tb04507.x.
Manna, F., Chimenti, F., Bolasco, A., Secci, D., Bizzarri, B., Befani, O., Turini, P., Mondovi, B., Alcaro, S., & Tafi, A. (2002). Inhibition of amine oxidases activity by 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives. Bioorganic & Medicinal Chemistry Letters, 12, 3629–3633. DOI: 10.1016/S0960-894X(02)00699-6.
Motulsky, H. (1984). GraphPad InStat version 3.01 for Windows 95 (GraphPad software). San Diego, CA, USA: GraphPad Software, Inc.
Ozdemir, Z., Kandilci, H. B., Gumusel, B., Calis, U., & Bilgin, A. A. (2008). Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-thienyl) pyrazoline derivatives. Archiv der Pharmazie, 341, 701–707. DOI: 10.1002/ardp.200800068.
Petit-Demouliere, B., Chenu, F., & Bourin, M. (2005). Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology, 177, 245–255. DOI: 10.1007/s00213-004-2048-7.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977). Behavioral despair in mice: a primary screening test for antidepressants. Archives Internationales de Pharmacodynamie et de Thérapie, 229, 327–336.
Prasad, Y. R., Rao, A. L., Prasoona, L., Murali, K., & Kumar, P. R. (2005). Synthesis and antidepressant activity of some 1,3,5-triphenyl-2-pyrazolines and 3-(2″-hydroxy naphthalen-1″-yl)-1,5-diphenyl-2-pyrazolines. Bioorganic & Medicinal Chemistry Letters, 15, 5030–5034. DOI: 10.1016/j.bmcl.2005.08.040.
Rani, M., Yusuf, M., Khan, S. A., Sahota, P. P., & Pandove, G. (2011). Synthesis, studies and in-vitro antibacterial activity of N-substituted 5-(furan-2-yl)-phenyl pyrazolines. Arabian Journal of Chemistry, in press. DOI: 10.1016/j.jscs.2011.02.012.
Siddiqui, N., Alam, P., & Ahsan, W. (2009). Design, synthesis, and in-vivo pharmacological screening of N,3-(substituted diphenyl)-5-phenyl-1H-pyrazoline-1-carbothioamide derivatives. Archiv der Pharmazie, 342, 173–181. DOI: 10.1002/ardp.200800130.
Vogel, H. G. (2002). Rotarod method. In Drug discovery and evaluation: Pharmacological assays (pp. 398). New York, NY, USA: Springer.
Youdim, M. B. H., Edmondson, D., & Tipton, K. F. (2006). The therapeutic potential of monoamine oxidase inhibitors. Nature Reviews Neuroscience, 7, 295–309. DOI: 10.1038/nrn-1883.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Das, N., Dash, B., Dhanawat, M. et al. Design, synthesis, preliminary pharmacological evaluation, and docking studies of pyrazoline derivatives. Chem. Pap. 66, 67–74 (2012). https://doi.org/10.2478/s11696-011-0106-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11696-011-0106-2